- Home
- PRPO vs LRE Comparison
PRPO vs LRE Comparison
Compare PRPO & LRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRPO
- LRE
- Stock Information
- Founded
- PRPO N/A
- LRE 2001
- Country
- PRPO United States
- LRE Japan
- Employees
- PRPO N/A
- LRE N/A
- Industry
- PRPO Biotechnology: Laboratory Analytical Instruments
- LRE
- Sector
- PRPO Industrials
- LRE
- Exchange
- PRPO Nasdaq
- LRE Nasdaq
- Market Cap
- PRPO 22.0M
- LRE 20.5M
- IPO Year
- PRPO N/A
- LRE 2023
- Fundamental
- Price
- PRPO $15.41
- LRE $1.31
- Analyst Decision
- PRPO
- LRE
- Analyst Count
- PRPO 0
- LRE 0
- Target Price
- PRPO N/A
- LRE N/A
- AVG Volume (30 Days)
- PRPO 10.3K
- LRE 69.2K
- Earning Date
- PRPO 08-13-2025
- LRE 01-01-0001
- Dividend Yield
- PRPO N/A
- LRE N/A
- EPS Growth
- PRPO N/A
- LRE N/A
- EPS
- PRPO N/A
- LRE N/A
- Revenue
- PRPO $21,242,000.00
- LRE $110,330,328.00
- Revenue This Year
- PRPO N/A
- LRE N/A
- Revenue Next Year
- PRPO N/A
- LRE N/A
- P/E Ratio
- PRPO N/A
- LRE N/A
- Revenue Growth
- PRPO 27.05
- LRE 3.92
- 52 Week Low
- PRPO $3.90
- LRE $1.10
- 52 Week High
- PRPO $16.89
- LRE $2.49
- Technical
- Relative Strength Index (RSI)
- PRPO 69.89
- LRE 30.97
- Support Level
- PRPO $14.04
- LRE $1.46
- Resistance Level
- PRPO $16.27
- LRE $1.53
- Average True Range (ATR)
- PRPO 0.64
- LRE 0.09
- MACD
- PRPO 0.10
- LRE -0.02
- Stochastic Oscillator
- PRPO 84.48
- LRE 20.51
About PRPO Precipio Inc.
Precipio Inc is a healthcare solutions company focused on cancer diagnostics. It focuses on addressing the problem of cancer misdiagnoses by developing solutions to mitigate the root causes of this problem in the form of diagnostic products, reagents, and services. The company operates Clinical Laboratory Improvement Amendments laboratories in both the New Haven, Connecticut and Omaha, Nebraska locations providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. It provides new technologies to the oncology diagnostic laboratory market in the form of HemeScreen and IV-Cell product offerings. The company generates the majority of its revenue from third-party payers.
About LRE Lead Real Estate Co. Ltd
Lead Real Estate Co Ltd operates as a developer of luxury residential properties, including single-family homes and condominiums, across Tokyo, Kanagawa prefecture, and Sapporo. The company also operates hotels in Tokyo and leases apartment building units to individual customers in Japan and Dallas, Texas. Predominantly, its revenue is generated from developing and selling single-family homes and condominiums. The company's sole operating segment is real estate sales. Geographically, it derives revenue from Japan.